Published in J Breast Cancer on September 24, 2015
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol (2014) 2.51
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol (1999) 2.22
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol (2000) 2.19
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol (2003) 1.75
Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol (2006) 1.38
Local-regional breast cancer recurrence: prognostic groups based on patterns of failure. Breast J (2002) 1.15
Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence. Int J Radiat Oncol Biol Phys (2008) 1.02
Molecular markers for prognosis after isolated postmastectomy chest wall recurrence. Cancer (2004) 0.93
Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res Treat (1997) 0.93
Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer. Cancer (1987) 0.91
Treatment results of breast cancer patients with locoregional recurrence after mastectomy. Radiat Oncol J (2013) 0.89
Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys (2000) 0.83
Radiotherapy for postmastectomy local-regional recurrent breast cancer. Am J Clin Oncol (2000) 0.81
Long-term survival following postmastectomy locoregional recurrence of breast cancer. Breast (1999) 0.79
Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer (2013) 1.22
Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report. Radiat Oncol J (2013) 0.94
Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer. Radiat Oncol J (2015) 0.90
Treatment results of breast cancer patients with locoregional recurrence after mastectomy. Radiat Oncol J (2013) 0.89
Development of new on-line statistical program for the Korean Society for Radiation Oncology. Radiat Oncol J (2015) 0.85
Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer. Radiat Oncol J (2014) 0.85
Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematol Oncol (2015) 0.83
Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancer. J Breast Cancer (2014) 0.82
A review of breast cancer survivorship issues from survivors' perspectives. J Breast Cancer (2014) 0.79
The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society. Ann Surg Treat Res (2015) 0.79
A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer. Cancer Res Treat (2014) 0.79
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer. J Breast Cancer (2013) 0.79
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea. Cancer Res Treat (2014) 0.78
Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer. Radiat Oncol J (2015) 0.78
Interobserver Variability of Ki-67 Measurement in Breast Cancer. J Pathol Transl Med (2016) 0.78
Incorporating Risk Factors to Identify the Indication of Post-Mastectomy Radiotherapy in N1 Breast Cancer Treated With Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23). Cancer Res Treat (2016) 0.78
Effects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study. Radiat Oncol J (2014) 0.77
Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma. J Med Imaging Radiat Oncol (2015) 0.77
Clinical outcomes of synchronous head and neck and esophageal cancer. Radiat Oncol J (2015) 0.76
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers. Cancer Chemother Pharmacol (2016) 0.76
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry. J Breast Cancer (2014) 0.76
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade. Genes Chromosomes Cancer (2016) 0.76
Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases. J Breast Cancer (2015) 0.75
Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study. J Breast Cancer (2016) 0.75
Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers. J Gynecol Oncol (2016) 0.75
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience. Blood Res (2014) 0.75
Using local flaps in a chest wall reconstruction after mastectomy for locally advanced breast cancer. Arch Plast Surg (2015) 0.75
Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy. PLoS One (2016) 0.75
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers. Cancer Res Treat (2016) 0.75
Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer. Cancer Res Treat (2016) 0.75
Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer. Radiat Oncol J (2016) 0.75
Genetic Predisposition of Polymorphisms in HMGB1-Related Genes to Breast Cancer Prognosis in Korean Women. J Breast Cancer (2017) 0.75
Reliability of the percent density in digital mammography with a semi-automated thresholding method. J Breast Cancer (2014) 0.75
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection. Clin Lung Cancer (2015) 0.75
Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection. J Clin Lab Anal (2020) 0.75
Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07). Cancer Res Treat (2017) 0.75
The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier. J Breast Cancer (2017) 0.75
Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer. Radiat Oncol J (2017) 0.75
Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papilloma. J Pathol Transl Med (2017) 0.75
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients. Blood Res (2017) 0.75
Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2. Radiat Oncol J (2017) 0.75
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus. Radiat Oncol J (2017) 0.75
Breast implant-associated anaplastic large cell lymphoma: the first South Korean case. J Pathol Transl Med (2020) 0.75
Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value. Sci Rep (2017) 0.75